Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1105 - Defining Signalotypes in Chronic Lymphocytic Leukemia and Applying Machine Learning to Better Characterize Biological and Clinical Subgroups

    Co-Author(s)

  • AD

    Asslaber Daniela, PhD

    Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria
    Salzburg, Salzburg, Austria

  • JF

    Jennifer Forster, MSc

    Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria
    Salzburg, Salzburg, Austria

  • NZ

    Nadja Zaborsky, PhD

    Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria
    Salzburg, Salzburg, Austria

  • FG

    Franz Gassner, PhD

    Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria
    Salzburg, Salzburg, Austria

  • TP

    Tea Pemovska, PhD

    Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria
    Vienna, Wien, Austria

  • PS

    Philipp Staber, MD

    Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria
    Vienna, Wien, Austria

  • RG

    Richard Greil, MD

    Professor
    Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria; Cancer Cluster Salzburg
    Salzburg, Austria

    • Primary Author / Presenter(s)

  • AE

    Alexander Egle, MD

    Professor
    Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR); Cancer Cluster Salzburg
    Salzburg, Austria